Application of urine biomarker detection reagent in preparation of new coronal pneumonia diagnostic kit

Abstract

The invention relates to the field of in-vitro diagnostic reagents, in particular to application of a reagent for detecting biomarkers in urine to preparation of a diagnostic kit for new coronal pneumonia. According to the invention, urine is used as a biological sample, so that the collection of a detection sample is greatly facilitated, and the infection risk of new coronavirus is reduced; the collection of the urine is non-invasive, so that the compliance of a person to be detected is also greatly improved; due to the fact that the detected urine indexes are few, the detection cost is remarkably reduced, the detection time is shortened, medical institutions can carry out the method more conveniently, meanwhile, the detected urine indexes are few, and the detection accuracy is equivalent to that of a traditional method. Therefore, the urgent requirement of clinical non-innovative coronary pneumonia examination can be well met.

Description

technical field [0001] The invention relates to the field of in vitro diagnostic reagents, in particular to the use of a urine biomarker detection reagent in the preparation of a diagnostic kit for novel coronavirus pneumonia. Background technique [0002] New coronavirus pneumonia (Corona Virus Disease 2019, COVID-19), referred to as "new coronary pneumonia", named "2019 coronavirus disease" by the World Health Organization, new coronavirus pneumonia is mainly manifested by fever, dry cough, fatigue, etc., a small number of patients Accompanied by upper respiratory and gastrointestinal symptoms such as nasal congestion, runny nose, and diarrhea. Severe cases mostly develop dyspnea after 1 week, and severe cases rapidly progress to acute respiratory distress syndrome, septic shock, metabolic acidosis that is difficult to correct, coagulation dysfunction, and multiple organ failure. It is worth noting that severe and critically ill patients may have moderate to low fever or ...

AI Technical Summary

Problems solved by technology

It can be seen that the current nucleic acid detection of new coronary pneumonia virus is prone to false negatives and false positives due to the irregular sampling. At the same time, the risk of infection of the samplers is high, and the implementation of invasive operations on the subjects can easily lead to physical discomfort.

Images